Sort
17,054 grants matching “genome editing”
Project 1. Gene Variants and Their Interactions Defining Human NTD Risk
$577,017Margaret Elizabeth Ross · Weill Medical Coll Of Cornell Univ · P01 · FY2018 · HD
Long-term microglia-targeted endogenous retrovirus-like particle (ERVLP) delivery of Cas12f editor to cure HIV
$576,854Wenhui Hu · Virginia Commonwealth University · R01 · FY2024 · DA
Long-term microglia-targeted endogenous retrovirus-like particle (ERVLP) delivery of Cas12f editor to cure HIV
$576,854Wenhui Hu · Virginia Commonwealth University · R01 · FY2025 · DA
Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease
$576,849Hayk Davtyan · University Of California-Irvine · R01 · FY2020 · AG
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
$576,627Sidi Chen · Yale University · R01 · FY2021 · CA
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
$576,627Sidi Chen · Yale University · R01 · FY2018 · CA
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
$576,627Sidi Chen · Yale University · R01 · FY2020 · CA
Lentiviral Gene Therapy and Genome Editing for X-linked Severe Combined Immunodeficiency
$576,217Stephen Gottschalk · St. Jude Children'S Research Hospital · P01 · FY2021 · HL
Lentiviral Gene Therapy and Genome Editing for X-linked Severe Combined Immunodeficiency
$576,217Stephen Gottschalk · St. Jude Children'S Research Hospital · P01 · FY2022 · HL
Lentiviral Gene Therapy and Genome Editing for X-linked Severe Combined Immunodeficiency
$576,217Stephen Gottschalk · St. Jude Children'S Research Hospital · P01 · FY2020 · HL
Development and Clinical Application of Gene and Cell therapies for Patients with Immune Deficiencies
$576,014Suk See De Ravin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
The SMAD3 signaling network in coronary artery disease risk
$576,002Thomas None Quertermous · Stanford University · R01 · FY2018 · HL
The SMAD3 signaling network in coronary artery disease risk
$576,002Thomas None Quertermous · Stanford University · R01 · FY2021 · HL
The SMAD3 signaling network in coronary artery disease risk
$576,002Thomas None Quertermous · Stanford University · R01 · FY2019 · HL
The SMAD3 signaling network in coronary artery disease risk
$576,002Thomas None Quertermous · Stanford University · R01 · FY2020 · HL
Molecular Analysis of Developmental Brain Disorders Associated with Synaptic Pathology
$575,925Scott H Soderling · Duke University · R01 · FY2021 · MH
Molecular Analysis of Developmental Brain Disorders Associated with Synaptic Pathology
$575,925Scott H Soderling · Duke University · R01 · FY2020 · MH
Stable therapy in Pompe disease through genome editing
$575,718Dwight D Koeberl · Duke University · R01 · FY2025 · AR
Apollo: Collaborative, Interactive Analytics and Annotation of Genome Variants
$575,700Suzanna E Lewis · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2017 · GM
Scalable Computational Methods for Genealogical Inference: from species level to single cells
$575,594Yun S. Song · University Of California Berkeley · R01 · FY2025 · HG
National Xenopus Resource Center
$575,532Marko E Horb · Marine Biological Laboratory · P40 · FY2024 · OD
Eradication of latent SIV from the CNS
$575,530Andrew G Maclean · Tulane University Of Louisiana · R01 · FY2017 · NS
Genetic Dissection of Cells and Organisms Training Grant
$575,530Jasper D Rine · University Of California Berkeley · T32 · FY2019 · GM
The Diversity Outbred Diabetes Project
$575,411Alan D Attie · University Of Wisconsin-Madison · R01 · FY2021 · DK
Alternative polyadenylation as a novel mechanism for diabetes
$575,363Qin Yang · University Of California-Irvine · R01 · FY2024 · DK